Filing Details

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 9)

_______________________

 

REGIONAL HEALTH PROPERTIES, INC.

(Name of Issuer)

 

10.875% Series A Cumulative Redeemable Preferred Stock

(Title of Class of Securities)

 

75903M200

(CUSIP Number of Class

of Securities)

_______________________

 

Charles L. Frischer

3156 East Laurelhurst Drive

Seattle, WA 98105

(917) 528-1465

______________________________________________________________________

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

January 17, 2023

(Date of Event which Requires Filing of this Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box ☐.

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

   

(continued on next page(s))

Page 1 of 7

 

 

13D

CUSIP No.  75903M200

Page 2 of 7

 

1	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person   Charles Frischer I.R.S. I.D. No.
2	Check the Appropriate Box if a Member of a Group *		(a) ☒ (b) ☐
3	SEC Use Only
4	Sources of Funds *   PF
5	Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(e) of 2(f)		☐
6	Citizenship or Place of Organization   USA
Number of Shares Beneficially Owned by Each Reporting Person With	7	Sole Voting Power   468,673
	8	Shared Voting Power   - 0 -
	9	Sole Dispositive Power   468,673
	10	Shared Dispositive Power   - 0 -
11	Aggregate Amount Beneficially Owned by Each Reporting Person   468,673
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares*		☐
13	Percent of Class Represented by Amount in Row (11)   16.7%
14	Type of Reporting Person*   IN

 

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 

13D

CUSIP No.  75903M200

Page 3 of 7

 

1	Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person   Libby Frischer Family Partnership I.R.S. I.D. No.
2	Check the Appropriate Box if a Member of a Group *		(a) ☒ (b) ☐
3	SEC Use Only
4	Sources of Funds *   WC
5	Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(e) of 2(f)		☐
6	Citizenship or Place of Organization   USA
Number of Shares Beneficially Owned by Each Reporting Person With	7	Sole Voting Power   11,000
	8	Shared Voting Power   - 0 -
	9	Sole Dispositive Power   11,000
	10	Shared Dispositive Power   - 0 -
11	Aggregate Amount Beneficially Owned by Each Reporting Person   11,000
12	Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares*		☐
13	Percent of Class Represented by Amount in Row (11)   0.4%
14	Type of Reporting Person*   PN

 

*SEE INSTRUCTIONS BEFORE FILLING OUT!

 

 

13D

CUSIP No.  75903M200

Page 4 of 7

 

This Amendment No. 9 to Schedule 13D (this “Amendment”) amends certain information contained in the Schedule 13D filed jointly by Charles Frischer and the Libby Frischer Family Partnership, a New York partnership, on January 26, 2018, as amended by Amendment No. 1 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on August 27, 2018, as amended by Amendment No. 2 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on December 3, 2018, as amended by Amendment No. 3 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on January 2, 2018, as amended by Amendment No. 4 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on December 4, 2019, as amended by Amendment No. 5 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on June 2, 2021, as amended by Amendment No. 6 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on July 1, 2021, and as amended by Amendment No. 7 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on March 7, 2022, as amended by Amendment No. 8 to Schedule 13D filed by Charles Frischer and the Libby Frischer Family Partnership on December 7, 2022 with respect to their interests in shares of 10.875% Series A Cumulative Redeemable Preferred Stock, no par value of Regional Health Properties, Inc., a Georgia corporation (the “13D”). Capitalized terms used but not defined herein have the meanings ascribed to them in the 13D. 

 

Item 3. Source and Amount of Funds of Other Consideration.

 

Item 3 is amended by adding the following:

 

Charles Frischer purchased 33,758 Shares in the aggregate from December 23, 2022 through January 17, 2023 for an aggregate purchase price of $99,414.20. Mr. Frischer used his personal funds to acquire these Shares.

 

Item 4. Purpose of Transaction:

 

Item 4 is amended by adding the following paragraph:

 

On March 1, 2023, Charles Frischer sent a letter to Brent Morrison, The Chief Executive Officer and President of the Issuer, response to the draft S-4 Registration Statement the Issuer filed on February 14, 2023 (the “Registration Statement”). In such letter, Mr. Frischer notified the Issuer of that he would not support the proposed exchange offer without the inclusion of additional change in control language to protect Series A Preferred holders in the event of a change in control transaction. A copy of Mr. Frischer’s letter is attached as an Exhibit to this Amendment.

 

Item 5. Interest of Securities of the Issuer.

 

Item 5 is amended as follows:

 

(a) and (b) Beneficial ownership

 

  

13D

CUSIP No.  75903M200

Page 5 of 7

  

As of the date of this Amendment No. 9 to Schedule 13D, the Partnership directly owns 11,000 Shares representing 0.4% of the total outstanding shares. As of the date of this Schedule 13D, Mr. Frischer directly or through his IRA owns 468,673 Shares and he is the sole general partner of the Partnership. Accordingly, Mr. Frischer indirectly beneficially owns 479,673 Shares representing approximately 17.1% of the outstanding Shares. The percentages set forth above and on the cover pages hereto represent percentages of the outstanding Shares based on a total of 2,811,535 Shares outstanding on November 11, 2022, which amount is derived from amount reported in the Issuer’s Quarterly Report on Form 10-Q for the period ended September 30, 2022.

 

By virtue of their status as a "group" for purposes of Rule 13d-5, each of the Reporting Persons may be deemed to have shared voting and dispositive power over the Shares owned by the other Reporting Persons. Each Reporting Person disclaims beneficial ownership of the Shares owned by the other Reporting Persons other than the Shares owned by the Partnership, which Mr. Frischer does not disclaim beneficial ownership.

 

Mr. Frischer has sole voting power and sole investment power with respect to 479,673 Shares.

 

(c)       Transactions during the past sixty days

 

Information with respect to each of the Reporting Persons transactions effected during the past 60 days are set forth on Annex A hereto.

 

(d)       Right to receive dividends or proceeds

 

Not applicable.

 

(e)       Beneficial ownership of less than five percent

 

Not applicable.

 

Item 7. Materials to be Filed as Exhibits.

 

1.

Joint Filing Agreement, incorporated by reference to Exhibit 1 to the 13D

2.

Letter to the Issuer dated March 1, 2023-Filed herewith

  

 

13D

CUSIP No.  75903M200

Page 6 of 7

 

Signatures

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Pursuant to Rule 13d-1(k), this Schedule 13D is filed jointly on behalf of each of the Reporting Persons.

 

Dated as of:  March 1, 2023

   

	/s/ Charles Frischer
	Charles Frischer
	LIBBY FRISCHER FAMILY PARTNERSHIP
	By:	/s/ Charles Frischer
		Charles Frischer
		General Partner

 

Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

   

   

13D

CUSIP No.  75903M200

Page 7 of 7

  

ANNEX A

 

Schedule of Transactions in Preferred Shares of the Issuer

During the Past 60 Days

 

Libby Frischer Family Partnership

 

None

 

Charles Frischer

 

Date of Transaction	Quantity Purchased	Price per Share
12/23/2022	1,700	$2.31
12/27/2022	6,158	$2.79
12/28/2022	2,900	$2.87
12/29/2022	4,400	$2.76
12/30/2022	10,606	$3.00
01/12/2023	700	$3.10
01/17/2023	7,294	$3.27

(1)

All purchases were effected through open market or privately negotiated transactions.